Amini: They play a significant role in how we treat metastatic lung cancer. All patients with stage IV disease should have ...
Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...
Amini: From a radiation standpoint, this has changed the landscape of our field. A large proportion of my practice is stage IV disease, where patients who are on these excellent systemic therapies are ...
The primary battleground in the competition for lung cancer treatments is shifting toward "brain metastasis." This shift comes as new research has ...
New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients ...
Researchers identify gene activity patterns linked to vascular invasion in lung cancer, enabling biopsy-based prediction of aggressive tumors, improving treatment decisions and recurrence risk ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung ...
Researchers reported at the 2026 European Lung Cancer Congress that Hernexeos (zongertinib) led to high response rates and ...
Researchers at the CU Anschutz Cancer Center have discovered how breast cancer cells that spread to the lungs may take ...
Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have ...
Learn how breast cancer cells exploit healing processes in the lungs to support tumor growth and what this means for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results